I agree with you 100%. I've just not seen any actually do this. I wish Missling could provide better data guidance, too. I'm sure he's not purposely providing inaccurate information. 70% of of all trials encounter delays... so it would seem that data analysis are also susceptible. All are dependent on 3rd-party contributors... then there's the potential impact of Sars-v2 and all its variants.